Opko Health, Inc 8-K/A, filed Feb 5, 2021
Opko Health, Inc. (OPK)
8-K/A
2021-02-05
For: 2021-02-01
View Original
Added on
April 06, 2026
About this 8-K/A
Opko Health, Inc filed this 8-K/A on February 5, 2021, reporting on events of February 1, 2021.
Items reported
- Item 5.02: Director or officer change, or executive pay
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 1, 2021
(Exact Name of Registrant as Specified in its Charter)
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||||||||
Registrant’s telephone number, including area code: (305 ) 575-4100
| Not Applicable | ||
| Former name or former address, if changed since last report | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Explanatory Note
This Amendment No. 1 on Form 8-K/A (this “Form 8-K/A”) is an amendment to the Current Report on Form 8-K of OPKO Health, Inc., filed on February 1, 2021 (the “Original Form 8-K”). Following the initial filing of the Original Form 8-K, the Registrant discovered that the wrong item number was inadvertently tagged in the submission. The Registrant is amending the Original Form 8-K solely to include the correct item number. No disclosure has been changed..
ITEM 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. | |||||||
Effective on February 1, 2021, Rulfo F. Hernandez, resigned from his position as Chief Accounting Officer, Treasurer and Global Corporate Controller of OPKO Health, Inc. (the “Company”). Mr. Hernandez’s resignation is not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
ITEM 9.01. | Financial Statements and Exhibits. | |||||||
| (d) | Exhibits | |||||||
| Exhibit No. | Description | |||||||
| 104 | Cover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OPKO Health, Inc. | |||||||||||
By: | /s/ Steven D. Rubin | ||||||||||
Date: February 5, 2021 | Name: | Steven D. Rubin | |||||||||
Title: | Executive Vice President-Administration | ||||||||||